NCT05689047: Phase IIa Proof of Concept Study of M5717-Pyronaridine in Adults and Adolescents With Acute Uncomplicated Plasmodium Falciparum Malaria (CAPTURE 1)
- State
- Completed
- Phase
- Phase 2
- People
- 38 taking part
- Started
- 29 Mar 2023
- Primary completion
- 28 May 2024
- Arms
- Part A: Safety Run-in Cohort M5717+Pyronaridine
- Results
- Posted on the registry
- 18 Jan 2023: Trial registered
- 29 Mar 2023: Trial started
- 28 May 2024: Trial completed
- 27 Aug 2025: Trial results posted